Carregant...
Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality of the studies. We collected data from 2003 to 20...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861183/ https://ncbi.nlm.nih.gov/pubmed/29594042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00062 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|